Literature DB >> 2056948

Extracorporeal techniques in the treatment of poisoned patients.

S M Pond1.   

Abstract

The role of haemodialysis, haemoperfusion and haemofiltration in the management of poisoned patients is reviewed in light of 15 years' clinical experience. During haemodialysis, blood is pumped across a semipermeable membrane (dialysis) through which the compound diffuses and, during haemoperfusion, through a cartridge that contains activated charcoal to which the compound is adsorbed. During haemofiltration, the constituents of blood that have a relative molecular mass which is below the cut-off point of the hollow fibre membrane (usually less than 40,000) are extracted. Haemofiltration is indicated particularly for aminoglycoside toxicity. The clearance by these three procedures depends on the physicochemical characteristics and kinetics of the toxic compound. In general, if a compound is adsorbed by charcoal, the clearance by haemoperfusion will be higher than that achieved by haemodialysis. Similarly, if a compound is amenable to removal by haemodialysis, its clearance will be greater than that achieved by haemofiltration. The indications for extracorporeal elimination depend on the clinical severity and complications of the overdose, the characteristics of the individual patient and the nature, dose and plasma concentrations of the toxic substance. It is generally accepted that extracorporeal elimination is worthwhile if it increases total body clearance by 30% or more. It has little or no value for intoxication caused by chloroquine, flecainide, methotrexate, paraquat, quinine, and tricyclic antidepressants. The complications of extracorporeal elimination which are encountered most frequently are: hypotension; blood loss; haematomas; metabolic disequilibria; mechanical problems such as air embolism; and, in the case of haemoperfusion, hypocalcaemia, thrombocytopenia and leukopenia. In practice, the compounds for which extracorporeal elimination is used most frequently are the alcohols, lithium and salicylate (haemodialysis) and theophylline (haemofiltration).

Entities:  

Mesh:

Year:  1991        PMID: 2056948

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  6 in total

Review 1.  Poisoning in children 3: common medicines.

Authors:  M Riordan; G Rylance; K Berry
Journal:  Arch Dis Child       Date:  2002-11       Impact factor: 3.791

Review 2.  Poisoning in children 1: general management.

Authors:  M Riordan; G Rylance; K Berry
Journal:  Arch Dis Child       Date:  2002-11       Impact factor: 3.791

Review 3.  Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Brian S Decker; David S Goldfarb; Paul I Dargan; Marjorie Friesen; Sophie Gosselin; Robert S Hoffman; Valéry Lavergne; Thomas D Nolin; Marc Ghannoum
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-12       Impact factor: 8.237

Review 4.  Pharmacokinetic considerations in clinical toxicology: clinical applications.

Authors:  Darren M Roberts; Nick A Buckley
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 5.  Clinical review: extracorporeal blood purification in severe sepsis.

Authors:  Ramesh Venkataraman; Sanjay Subramanian; John A Kellum
Journal:  Crit Care       Date:  2003-02-21       Impact factor: 9.097

6.  An improved method for removal of azo dye orange II from textile effluent using albumin as sorbent.

Authors:  Tadashi Ohashi; Alícia M T Jara; Anabelle C L Batista; Luciana O Franco; Marcos A Barbosa Lima; Mohand Benachour; Carlos A Alves da Silva; Galba M Campos-Takaki
Journal:  Molecules       Date:  2012-11-30       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.